Dave Lashmet undertakes an intensive research process to discover under-the-radar technology, biotechnology, and medical companies poised for near-term growth. He was one of the first employees at Stansberry Research and is the editor of Stansberry Venture Technology. His unique insight into new technologies is responsible for some of the biggest gains in the history of the firm. Dave has spent 10 years teaching and writing about medicine and technology at major research universities, and he has done follow-up research at some of the most important facilities in North America, like Harvard Medical School, Johns Hopkins, MIT, and the Centers for Disease Control and Prevention.